Tempus AI vs Vanguard Short Term Corporate Bond ETF — how do they compare? Tempus AI trades at $55.45 (market cap $9.93B), while Vanguard Short Term Corporate Bond ETF trades at $78.52. The key difference: Tempus AI is trading nearer its 52-week high, Vanguard Short Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| TEM | VCSH | |
|---|---|---|
Market Cap | $9.93B | — |
Sector | Broad Market / Factor | Fixed Income |
52-Week High | $103.25 | $80.20 |
52-Week Low | $41.55 | $78.41 |
Enterprise Value | $10.56B | — |
Signals from Pluang's Aura AI — not financial advice
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
VCSH trades at $78.61, up 0.17% with neutral technical signals. The ETF offers a short 2.7-year duration and a 4.77% yield, attracting income-focused investors amid stable rate expectations. Recent institutional activity shows mixed positioning, with some firms reducing stakes while others increase holdings. Credit spreads remain tight, limiting near-term upside potential but providing downside protection.
Outlook is cautious due to unattractive entry points and tight spreads. The ETF suits conservative portfolios seeking steady income with low volatility, though limited rate cuts in 2026 may cap gains. Risks include credit spread widening and competition from higher-yielding alternatives.
Trailing returns across standard periods
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →